Stifel Financial’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-788
Closed -$20.7K 3437
2022
Q4
$20.7K Sell
788
-180
-19% -$8.54K ﹤0.01% 3241
2022
Q3
$98K Sell
968
-36
-4% -$4.87K ﹤0.01% 3108
2022
Q2
$142K Buy
1,004
+144
+17% +$20.1K ﹤0.01% 3095
2022
Q1
$136K Buy
860
+280
+48% +$45.2K ﹤0.01% 3214
2021
Q4
$129K Buy
580
+140
+32% +$27.1K ﹤0.01% 3235
2021
Q3
$85K Sell
440
-100
-19% -$21.2K ﹤0.01% 3253
2021
Q2
$130K Buy
540
+20
+4% +$5.48K ﹤0.01% 3212
2021
Q1
$176K Buy
+520
New +$211K ﹤0.01% 3043

Other funds holding TFFP

Stifel Financial's TFFP Position: Q1 2023 in Review

Stifel Financial sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2023, closing a stake of 788 shares — an estimated $20.7K sold.

Stifel Financial first reported a position in TFFP in Q1 2021 and held it in 8 quarters. The position peaked at $176K in Q1 2021. 36 funds tracked by Wall St. Rank hold TFFP as of Q1 2023.

  • Stifel Financial reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Stifel Financial sold 788 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $20.7K.
  • Stifel Financial first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Stifel Financial's TFF Pharmaceuticals, Inc. Common Stock position peaked at $176K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Stifel Financial's 13F filing for Q1 2023, filed 12 May 2023.